Companies / Outlook Therapeutics, Inc. / Activity
Activity — Outlook Therapeutics, Inc.
7 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Q2 2026 as of | Deutsche Bank AG 13F manager | New | Common Stock | $207.8K | +131K | 130,700 0.11% of shares | low |
| Q1 2024 as of | Barclays PLC 13F manager | New | Common Stock | $65.6K | +5K | 5,496 <0.01% of shares | low |
| Q2 2025 as of | Sanctuary Advisors, LLC 13F manager | New | Common Stock | $58.1K | +36K | 36,286 0.03% of shares | low |
| Q1 2026 as of | Renaissance Technologies LLC 13F manager | New | Common Stock | $52.5K | +255K | 255,157 0.21% of shares | low |
| Q2 2026 as of | Signet Private Wealth LLC 13F manager | New | Common Stock | $27.9K | +18K | 17,555 0.01% of shares | low |
| Q4 2025 as of | IFP Advisors, Inc 13F manager | New | Common Stock | $79 | +50 | 50 <0.01% of shares | low |
| Q2 2026 as of | SG Americas Securities, LLC 13F manager | New | Common Stock | $27 | +17K | 17,271 0.01% of shares | low |